Presentation is loading. Please wait.

Presentation is loading. Please wait.

Www.centaurpharma.com We Impart Health to Life Provide end-to-end pharmaceuticals solutions Centaur Pharmaceuticals Pvt. Ltd. www.centaurpharma.com We.

Published byRolf Richardson Modified over 9 years ago

Similar presentations

Presentation on theme: "Www.centaurpharma.com We Impart Health to Life Provide end-to-end pharmaceuticals solutions Centaur Pharmaceuticals Pvt. Ltd. www.centaurpharma.com We."— Presentation transcript:

1 www.centaurpharma.com We Impart Health to Life Provide end-to-end pharmaceuticals solutions Centaur Pharmaceuticals Pvt. Ltd. www.centaurpharma.com We Impart Health to Life

2 www.centaurpharma.com We Impart Health to Life Business Spread (Sales)Geographical Spread (Sales) Corporate API Formulations Domestic Sales International Sales 31% 69% 22% 78%

3 www.centaurpharma.com We Impart Health to Life Established 1978 Rank 51 - IMS-ORG (India) Rank 45 - Rx audit- CMARC Exports to 95 countries Competencies across the pharmaceutical value chain Corporate ORG Nov11/CMARC Jul-Oct11/AWACS Dec11

4 www.centaurpharma.com We Impart Health to Life Our assets- 2000 Centaurians API 110 Centaur House 230 Formulations Facilities 450 Sales Force 1150 CRO 60

5 www.centaurpharma.com We Impart Health to Life Contract Manufacturing, Pune www.centaurpharma.com We Impart Health to Life  Fully scalable formulations facility 25,000 square metres  Approved by USFDA, UK MHRA, TGA, Health Canada  Annual capacity 3 billion tablets & 600 million capsules  Formulations and Analytical R&D  On the anvil, Ophthalmics–12 million units pa

6 www.centaurpharma.com We Impart Health to Life WHO-GMP Approved Formulations Facilities- Goa PlantDepartmentCapacityUnitBuilt Up Area Sq M Plant ILiquids25Million L 3577 Tablets & Capsules600Million Vials (Sterile)10Million L Plant II OintmentsTopical 0.75 Sterile 0.2 Tonnes1280

7 www.centaurpharma.com We Impart Health to Life API, Ambernath India's largest Psychotropic API player, introduced 28 API in India USFDA / AFSSAPS approved Proficiency- Conceptualisation to Commercialisation Clientele: Big Pharma and generic majors

8 www.centaurpharma.com We Impart Health to Life  Exports to Asia, Americas, Africa  India- 50 million+ Rx annually  Brand leader in 6 therapy segments  1145 Sales force, 10,000 Drs and 10,000 pharmacies daily Formulations Marketing 1 Rx / Second 33Mn Rx / Year

9 www.centaurpharma.com We Impart Health to Life Total Sales Force 1145 TeamMRManagerTotalSales Share % Focus Specialities Samruddhi 40095495 43ENT, Chest, Physicians Shasvatam 32871399 44 Paediatricians, Dermatologists Praggya 12528153 11Ophthalmologists, ENT Sankalp 791998 2 Cardiologists, Diabetologists, Nephrologists Centaur 9322131145 100All teams cover GP

10 www.centaurpharma.com We Impart Health to Life Contract Research Fully integrated set-up- BA / BE / Clinical trials (Phase II/III) International standard CRO -10,000 sq.ft. 42 bed CPU, fully-equipped ICU Formulations & API development

11 www.centaurpharma.com We Impart Health to Life PartnerCountryMoleculeIndicationStatus JapanSorivudine Topical antiviral for Herpes Zoster Development & distribution rights for India++ Centaur to conduct PII/PIII trials, launch 2014 Japan Timolol LAGlaucoma Launched 2011 BromfenacNSAID Launch 2012 Germany DPOCL (Diperoxochloric Acid) Diabetic Foot Ulcer solution NCE, development rights Phase II successful Phase III WIP Launch by 2013 Strategic Alliances Strategy- Harness CRO, API & marketing proficiencies

12 www.centaurpharma.com We Impart Health to Life Strategic Alliances APIContract Manufacturing Contract Research EUSynthon, EGIS, Stada, NTIM, Mylan, Pfizer, Mayoli Spindler GSK, Blue Fish NRIM, Zanza, Wockhardt, Aurobindo, Bluemont Wessex, Kirka Orion,Hennig- Arzneimittel, AmericasSepracor, Pharmascience, Actavis, Lab Teuto, Ratiopharm, Apotex, Caraco, Mylan, Sandoz Allergan, Euro Pharma, STI, Ingenus, IPG AfricaDelta Pharma, Al-andalous, Cooper Moroc IndiaWyeth, Sun Pharma, Intas, Zydus, Alcon, Nicholas Sanofi-Aventis, Novartis Inventia Rest of APac Rodan, IndusPharma, Sami Pharma, Wilshire Labs, ACME, Healthcare, General, Delta, Sandoz Generic Partners, Thinz

13 www.centaurpharma.com We Impart Health to Life API Contract Manufacturing Contract Research Formulations USFDA/EU API proficiencies BA/BE studies Clinical trials R&D Pan India 1145 Sales Force 50,000,000 Rx 250,000 Drs and pharmacies / month USFDA/ UKMHRA/ TGA World scale capacity Why Centaur

14 www.centaurpharma.com We Impart Health to Life 20112016 Formulations API Contract Research Contract Manufacturing Future

15 www.centaurpharma.com We Impart Health to Life Centaur Pharmaceuticals Pvt. Ltd. Centaur House, Vakola, Santacruz (E), Mumbai-400 055. INDIA Tel. : +91-22-6649 9100 Fax : +91-22-6649 9108 / 112 Website: www.centaurpharma.comwww.centaurpharma.com Email: centaur@centaurlab.comcentaur@centaurlab.com BusinessE mail / WebsiteWebsite API & Formulations export@centaurchem.comwww.centaurchem.com www.centaurpharma.com Contract Manufacturing centaur_pune@centaur.co.inwww.centaurpharma.com Contract Research lifesan@lifesan.inwww.lifesan.in Contact

Download ppt "Www.centaurpharma.com We Impart Health to Life Provide end-to-end pharmaceuticals solutions Centaur Pharmaceuticals Pvt. Ltd. www.centaurpharma.com We."

Similar presentations

CORPORATE PROFILE Centaur Pharmaceuticals Pvt. Ltd. API Formulations

CORPORATE PROFILE Centaur Pharmaceuticals Pvt. Ltd. API Formulations
Www.centaurpharma.com We Impart Health to Life Provide end-to-end pharmaceuticals solutions Centaur Pharmaceuticals Pvt. Ltd. www.centaurpharma.com We.

We Impart Health to Life Provide end-to-end pharmaceuticals solutions Centaur Pharmaceuticals Pvt. Ltd. We.
Estimated Market Size 2006 (US$M)$503 5-Year CAGR (Taka Base)9.27% 5-Year CAGR (US $ Base)4.50% Bangladesh Pharmaceutical Market.

Estimated Market Size 2006 (US$M)$503 5-Year CAGR (Taka Base)9.27% 5-Year CAGR (US $ Base)4.50% Bangladesh Pharmaceutical Market.
“Global Generic Pharmaceutical Conference 2006”

“Global Generic Pharmaceutical Conference 2006”
Torrent Pharmaceuticals Ltd Investor Presentation FY 2011.

Torrent Pharmaceuticals Ltd Investor Presentation FY 2011.
Pharmaceuticals Limited India – CIS International Pharma Conference 3-5 th March 2006, Mumbai Prashant Nagre Vice President – API Division.

Pharmaceuticals Limited India – CIS International Pharma Conference 3-5 th March 2006, Mumbai Prashant Nagre Vice President – API Division.
About Us… LOCATIONDOSAGE FORMAPPROVALS GOA I TABLETS, CREAMS & OINTMENTS US-FDA EU-GMP TGA Australia MCC South Africa ANVISA – Brazil GOA II STERILE.

About Us… LOCATIONDOSAGE FORMAPPROVALS GOA I TABLETS, CREAMS & OINTMENTS US-FDA EU-GMP TGA Australia MCC South Africa ANVISA – Brazil GOA II STERILE.
Corporate Presentation INDOCO REMEDIES LTD. About Us  Indian Company with an International presence  Turnover 09-10; Rs. 402.36 Crores  Among the fastest.

Corporate Presentation INDOCO REMEDIES LTD. About Us  Indian Company with an International presence  Turnover 09-10; Rs Crores  Among the fastest.
INDOCO REMEDIES LTD 1. Company Profile  A fast growing, fully integrated, research oriented pharmaceutical company with a Global presence.  Strong domestic.

INDOCO REMEDIES LTD 1. Company Profile  A fast growing, fully integrated, research oriented pharmaceutical company with a Global presence.  Strong domestic.
HISTORY MCPL India Pvt. Ltd. Mr. Eric Menezes founded M.C.P.L (India) Pvt. Ltd in 1994 and was the first pioneer to introduce deodorant body sprays into.

HISTORY MCPL India Pvt. Ltd. Mr. Eric Menezes founded M.C.P.L (India) Pvt. Ltd in 1994 and was the first pioneer to introduce deodorant body sprays into.
Indian Pharma Industry - At The Helm

Indian Pharma Industry - At The Helm
Hale & Tempest Trends in the Pharmaceutical Industry and the Potential Impact on Future Innovation and Access to Medicines Dr. Brian W Tempest www.briantempest.com.

Hale & Tempest Trends in the Pharmaceutical Industry and the Potential Impact on Future Innovation and Access to Medicines Dr. Brian W Tempest
About Us… LOCATIONDOSAGE FORMAPPROVALS GOA I TABLETS, CREAMS & OINTMENTS US-FDA EU-GMP TGA Australia MCC South Africa ANVISA – Brazil GOA II STERILE.

About Us… LOCATIONDOSAGE FORMAPPROVALS GOA I TABLETS, CREAMS & OINTMENTS US-FDA EU-GMP TGA Australia MCC South Africa ANVISA – Brazil GOA II STERILE.
The Pharma Professional An industry focused learning program for students of pharmaceutical sciences Session 3 1 st March 2014 NIPER Hyderabad.

The Pharma Professional An industry focused learning program for students of pharmaceutical sciences Session 3 1 st March 2014 NIPER Hyderabad.
“SHOW CASING A.P.” FAPCCI Seminar on “Meeting Global Outsourcing Requirement” PRESENTATION By DR.P.V.APPAJI M.Pharm, Ph.D EXECUTIVE DIRECTOR PHARMEXCIL.

“SHOW CASING A.P.” FAPCCI Seminar on “Meeting Global Outsourcing Requirement” PRESENTATION By DR.P.V.APPAJI M.Pharm, Ph.D EXECUTIVE DIRECTOR PHARMEXCIL.
Critical Success Factors for the Korean Generic and API Industry in a post FTA Environment DAVID HARDING SEOUL JUNE 28-29, 2007.

Critical Success Factors for the Korean Generic and API Industry in a post FTA Environment DAVID HARDING SEOUL JUNE 28-29, 2007.
March, 2012 CORPORATE PRESENTATION. The essence of life…

March, 2012 CORPORATE PRESENTATION. The essence of life…
1 Global New Employee Orientation Workshop Welcome.

1 Global New Employee Orientation Workshop Welcome.
Corporate Presentation INDOCO REMEDIES LTD. About Us  Indian Company with an International presence  Turnover 09-10; Rs. 402.36 Crores,  Turnover 1.

Corporate Presentation INDOCO REMEDIES LTD. About Us  Indian Company with an International presence  Turnover 09-10; Rs Crores,  Turnover 1.
The intra and inter-firm geography of EMNCs: India’s pharmaceuticals Rory Horner Clark University Graduate School of Geography Presentation for ‘Emerging.

The intra and inter-firm geography of EMNCs: India’s pharmaceuticals Rory Horner Clark University Graduate School of Geography Presentation for ‘Emerging.

Similar presentations

Ads by Google